Navigation Links
Amgen and Onyx Pharmaceuticals Announce Upcoming Data Presentations at 55th American Society of Hematology Annual Meeting
Date:11/7/2013

  All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbursement activities and outcomes and other such estimates and results.  Forward-looking statements involve significant risks and uncertainties, including those discussed below and more fully described in the Securities and Exchange Commission (SEC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and any subsequent periodic reports on Form 10-Q and Form 8-K.  Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional information on the uncertainties and risk factors related to our business.  Unless otherwise noted, Amgen is providing this information as of Oct. 4, 2013, and expressly disclaims any duty to update information contained in this news release.

No forward-looking statement can be guaranteed and actual results may differ materially from those we project.  Discovery or identification of new product candidates or development of new indications for existing products cannot be guaranteed and movement from concept to product is uncertain; consequently, there can be no guarantee that any particular product candidate or development of a new indication for an existing product will be successful and become a commercial product.  Further, preclinical results do not guarantee safe and effective performance of product candidates in humans.  The complexity of the human body cannot be perfectly, or sometimes, even adequately modeled by computer or cell culture systems or animal models.  The length of time that it takes for us to complete clinical trials and obtain regulatory approval for product marketing has in the
'/>"/>

SOURCE Onyx Pharmaceuticals, Inc.; Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy
2. Amgen Presents Final Results from the Largest Phase 3 Open-Label Study Assessing the Safety and Efficacy of Nplate® (Romiplostim)
3. Amgen Announces 2012 First Quarter Dividend
4. Kevin Sharer, Amgen Chairman and CEO, Announces Plan to Retire With Robert Bradway to Become CEO on May 23, 2012; Sharer Will Continue as Chairman of the Board Until End of 2012
5. Amgen to Present at the 30th Annual J.P. Morgan Global Healthcare Conference
6. Amgen Announces Webcast of 2011 Fourth Quarter and Full Year Financial Results
7. Amgen to Acquire Micromet
8. Amgen to Present at the Leerink Swann Global Healthcare Conference
9. Amgen Announces 2012 Third Quarter Dividend
10. Amgen Names Ray Jordan Senior Vice President, Corporate Affairs
11. Amgen To Present At The 24th Annual Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014  Age Defying Dermatology ® ... , has become one of the first clinics in ... "picoseconds" aesthetic laser for tattoo removal. The treatment safely ... results. "For years, tattoo removal has been a lengthy, ... Noodleman. "This is an opportunity to erase tattoo pigment ...
(Date:9/23/2014)... , Sept. 23, 2014 /PRNewswire/ - Portage Biotech Inc. ... Exchange: PBT.U), is pleased to announce that its ... added two more  consultants to its team for ... uses a new proprietary cell permeable peptide platform ... anti-inflammatory cargo into the eye. ...
(Date:9/23/2014)... Mass. (PRWEB) September 23, 2014 Cambridge ... by Semantic Web technology, was named in the recent ... Gartner, Inc. , The report details key insights ... , According to Gartner analysts Michael Shanler and ... accelerate innovation activities, expose complex relationships with scientific stakeholders, ...
(Date:9/23/2014)... September 23, 2014 Equashield ... Transfer     Devices  (CSTD) for hazardous ... MedFront Medical Technology Corporation.  Equashield,s leading CSTD has ... Taiwan , China ... continues to expand globally, and throughout the ...
Breaking Biology Technology:Age Defy Now Offers World's Most Advanced Technology for Tattoo Removal 2Portage Announces New Consultants for its PPL-003 Development Programs 2Portage Announces New Consultants for its PPL-003 Development Programs 3Portage Announces New Consultants for its PPL-003 Development Programs 4Cambridge Semantics Identified in Gartner’s ‘Hype Cycle for Life Sciences 2014’ Report 2Equashield Enters Taiwan Following Expansion to Australia, Japan, China 2
... together state and national governments will be the ... and Technology Conference , held April 12 at ... "Regional Cooperation and Innovation", focuses on bringing different ... and Congressional reform. By briefing them on these ...
... billion bond initiative to fund stem-cell research, under pressure from ... interest. , ,Ten of the initiative's 29 board members hold ... companies, the Sacramento Bee reported. They won't have to relinquish ... Institute of Regenerative Medicine will have to give up or ...
... released its 2005 Greater Madison Area Directory of ... area firms. WTN's Mike Klein takes you inside ... Wisconsin. Original air date: Saturday, April 9, 2005 ... Read more news coverage ...
Cached Biology Technology:Midwest telecom conference to push government cooperation 2
(Date:9/23/2014)... the washing up, negotiating rights to the TV remote control ... university for the new academic year are about to learn ... business. , And now research from academics at The University ... to monitor their energy usage in the home could be ... a team of technology experts and psychologists found that meters ...
(Date:9/23/2014)... -- Research and Markets  has announced the addition ... 2019" report to their offering. ... and protection in private as well as government establishments ... is focusing on using biometric systems to store vital ... that are of crucial importance to the country. ...
(Date:9/23/2014)... Most organisms, including humans, have parasitic DNA fragments called ... genetic instructions in the process. And that phenomenon can ... at the University of Rochester now report that the ... age when a multi-function protein stops keeping them in ... , In a study published today in Nature ...
Breaking Biology News(10 mins):Smart meters could cause conflict for housemates, study shows 2Smart meters could cause conflict for housemates, study shows 3India Biometrics Market Forecast and Opportunities, 2019 2India Biometrics Market Forecast and Opportunities, 2019 3A multi-function protein is key to stopping genomic parasites from 'jumping' 2
... the study of biological, technological, and social complexity -- ... In a May 1 Nature paper, Hierarchical structure ... Fe Institute (SFI) researchers Aaron Clauset, Cristopher Moore, and ... understood as a hierarchy of modules, where nodes cluster ...
... HOUSTON, Texas The first year of ConocoPhillips ... State University (ISU) has supported 26 research projects ... diversify Americas sources of energy and help meet ... energy company in the United States, provided $1.75 ...
... Bacteria that feed on seaweed could help in the ... a new study by researchers in China and Japan. ... Biotechnology, an Inderscience publication. Shinichi Nagata of the ... colleagues at Shimane University and at Nankai University, China, ...
Cached Biology News:Nature paper describes technique for extracting hierarchical structure of networks 2Iowa State-ConocoPhillips collaboration advances 26 research projects in first year 2Wakame waste 2
HAMP Immunogen: HAMP (AAH20612, 25 a.a. ~ 85 a.a) full length recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
... peptide transporter 2 (APT2) ... transporter PSF2) (Peptide supply ... transporter involved in antigen ... Antigen: ...
Raised to arginine vasopressin coupled to bovine thyroglobulin with carbodiimide ....
Chicken polyclonal to HAGH ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to N terminal amino acids 110-260 of Human HAGH. Entrez GeneID: 3029 Swiss ...
Biology Products: